Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-08-31
1995-08-08
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514242, 514253, 514254, 514269, 514272, 514273, 514274, 514285, 514287, 514292, 546 81, 546 82, 546 83, 546 84, 546 64, 546 70, 544182, 544238, 544246, 544247, 544249, 544250, 544405, A61K 3138, A61K 31395, C07D47104, C07D23904
Patent
active
054399165
ABSTRACT:
Novel polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives are disclosed which are useful for treating allergic reactions, inflammation, peptic ulcers, hypertension, and hyperproliferative skin diseases and for suppressing the immune response in mammals. Methods for preparing said compounds are also disclosed.
REFERENCES:
patent: 3931199 (1976-01-01), Nakanishi et al.
patent: 3931205 (1976-01-01), Nakanishi et al.
patent: 3947449 (1976-03-01), Durchkheimer et al.
patent: 4596809 (1986-06-01), Sherlock
patent: 4680297 (1987-07-01), Blythin et al.
patent: 4680298 (1987-07-01), Blythin
patent: 4687774 (1987-08-01), Smith et al.
patent: 4760073 (1988-07-01), Blythin et al.
patent: 4801589 (1989-01-01), Smith et al.
patent: 4882332 (1989-11-01), Siegel et al.
Fournier et al., Bulletin De La Societe Chimique De France, 1968, No. 1, pp. 364-369.
Chem. Ab. vol. 96: NO. 217821K.
Hawkins, et al., Chem. Soc. Perkins Tans. I, 1983, pp. 2077-2087.
Chem. Ab. vol. 85, No. 108567: p. 455 (1976).
Chemical Abstracts. vol. 101, Abstract No. 38382t, 1984.
Chem. Abstracts, 91(5): 32785e (1979) pp. 33.
Bernath, et al., J. Heterocycl. Chem., 16(1), 137-44 (1979).
Chem. Abstracts, 88(13): 89668m (1978) pp. 522.
Chem. Abstracts, (85)3: 21376x (1976) pp. 695.
Chem. Abstracts, 74(15): 74797q (1971) pp. 303.
Chem. Abstracts, 85(7): 46621m (1976) pp. 536.
Chem. Abstracts, 90(25): 203821z (1979) pp. 600-601.
Chem. Abstracts, 93(5): 46364v (1980) pp. 902.
Chem. Abstracts, 95(13): 115339w (1981) pp. 686.
Chem. Abstracts, 80(19): 108503g (1974) pp. 419.
Chem. Abstracts, 82(1): 4230r (1976) pp. 367-368.
Chem. Abstracts, 88(19): 130847j (1978) pp. 32.
Chem. Abstracts, 93(19): 186323f (1980) pp. 863.
Chem. Abstracts, 88(3): 22701y (1978) pp. 617.
Chem. Abstracts, 87(17): 127017n (1977) pp. 28.
Chem. Abstracts, 84(9): 59429j (1976) pp. 522.
Chem. Abstracts, 67(9): 43655t (1967) pp. 428-431.
Chem. Abstracts, 97(11): 92173n (1982) pp. 761.
Chem. Abstracts, 86(7): 43594q (1977) pp. 536.
Chem. Abstracts, 91(15): 123609s (1979) pp. 588.
Chem. Abstracts, 98:215861n (1983) pp. 584.
Chem. Abstracts, 69: 67264q (1968) 6280-6281.
Khim-Farm zh. 10(5) pp. 18-22 (1976).
Chem. Ab. 70 (1969) No. 77902y pp. 348-349.
Zh. Obshch. Khim. 38(9) pp. 2051-2064 (1968).
Australian J. Chem. vol. 27 pp. 1295-1308 D. J. Gale.
Liebigs Annalen der Chemie (1984) F. Eiden pp. 1759-1777.
Chem. Abstracts, 91(5): 32785e (1979) p. 33.
Friary Richard J.
Ganguly Ashit K.
Schwerdt John H.
Siegel Marvin I.
Smith Sidney R.
Blasdale John H. C.
Nelson James R.
Richter Johann
Schering Corporation
LandOfFree
Polycyclic quinoline, naphthyridine and pyrazinopyridine derivat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polycyclic quinoline, naphthyridine and pyrazinopyridine derivat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polycyclic quinoline, naphthyridine and pyrazinopyridine derivat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-971394